pre-seed
Stage
1
Investors
About
Develops technology to maintain the viability of human tissues and tumors ex vivo to support cancer research and treatment testing. The platform is intended to enable studies and therapeutic evaluation using living human tumor and tissue samples outside the body.
Explore Keliomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.